Claris Biotherapeutics Funding: $57M Raised, Series A (2024)
Claris Biotherapeutics is based in Jersey City, New Jersey. It has raised $57M in total funding. Latest round: Series A.
Claris Biotherapeutics funding overview
Claris Biotherapeutics is based in Jersey City, New Jersey. Claris Biotherapeutics has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Claris Biotherapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings A/S, RA Capital Management, Mass General Brigham Ventures, Janus Henderson Investors. 4 distinct backers are named across the disclosed rounds.
Claris Biotherapeutics at a glance
Total raised
$57M
Latest round
Series A
Latest round date
January 2024
Headquarters
Jersey City, New Jersey
Notable investors
Novo Holdings A/S, RA Capital Management, Mass General Brigham Ventures, Janus Henderson Investors
Frequently asked about Claris Biotherapeutics funding
How much has Claris Biotherapeutics raised?
Claris Biotherapeutics has raised $57M in total disclosed funding across the rounds on record.
Who has invested in Claris Biotherapeutics?
Novo Holdings A/S, RA Capital Management, Mass General Brigham Ventures, Janus Henderson Investors are named among the investors backing Claris Biotherapeutics.
What was the latest Claris Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Claris Biotherapeutics based?
Claris Biotherapeutics is based in Jersey City, New Jersey.
When did Claris Biotherapeutics last raise?
The last disclosed Claris Biotherapeutics round closed in January 2024 at Series A.
We update the Claris Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Jersey City and their backers are listed below.
